Extracorporeal membrane oxygenation in cardiovascular medication poisoning. A German-wide retrospective study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 Sep 2024
Historique:
received: 10 05 2024
accepted: 09 09 2024
medline: 19 9 2024
pubmed: 19 9 2024
entrez: 18 9 2024
Statut: epublish

Résumé

Medication poisoning, resulting from the ingestion of cardiotoxic drugs, presents a significant health issue. The mortality rate remains high for patients with myocardial dysfunction refractory to conventional treatments. Venoarterial Extracorporeal Membrane Oxygenation (V-A ECMO) provides temporary support, potentially enhancing patient outcomes. This study aims to assess the efficacy of V-A ECMO in treating cardiovascular failure induced by cardiovascular medication poisoning. We utilized inpatient data from all hospitalisations in Germany from 2007 to 2022 due to cardiovascular medication poisoning treated with V-A ECMO. Patient characteristics, comorbidities, complications and application of ECMO were described descriptively and analysed for statistical significance between survivors and non-survivors. Overall, 49 patients received V-A ECMO for cardiovascular medication poisoning, with a survival rate of 63.6%. The most ingested medications were calcium-channel blockers (38.8%) and beta-adrenoceptor antagonists (34.7%). Half of non-survivors received in-hospital CPR, compared to 12.9% of survivors. Early ECMO implantation (within 24 h of admission) was common (83.7%) but did not significantly impact survival rates. A substantial number of patients presented with multiple substances ingested. V-A ECMO represents a viable option for patients experiencing cardiac failure due to medication poisoning. A structured implementation of V-A ECMO for cardiovascular medication poisoning could lead to higher survival rates.

Identifiants

pubmed: 39294292
doi: 10.1038/s41598-024-72547-0
pii: 10.1038/s41598-024-72547-0
doi:

Substances chimiques

Calcium Channel Blockers 0
Cardiovascular Agents 0
Adrenergic beta-Antagonists 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21761

Informations de copyright

© 2024. The Author(s).

Références

Gummin, D. D. et al. 2021 Annual Report of the National Poison Data System© (NPDS) from America’s Poison Centers: 39th Annual Report. Clin. Toxicol. (Phila) 60(12), 1381–1643. https://doi.org/10.1080/15563650.2022.2132768 (2022).
doi: 10.1080/15563650.2022.2132768 pubmed: 36602072
Wolkove, N. & Baltzan, M. Amiodarone pulmonary toxicity. Can. Respir. J. 16(2), 43–48. https://doi.org/10.1155/2009/282540 (2009).
doi: 10.1155/2009/282540 pubmed: 19399307 pmcid: 2687560
Lodhi, F. A. K. et al. Calcium channel blocker toxicity causing acute respiratory distress syndrome: A commonly used drug triggering a life-threatening condition. WMJ 119(1), 66–68 (2020).
pubmed: 32348076
Makdisi, G. & Wang, I. W. Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology. J. Thorac. Dis. 7(7), E166–E176. https://doi.org/10.3978/j.issn.2072-1439.2015.07.17 (2015).
doi: 10.3978/j.issn.2072-1439.2015.07.17 pubmed: 26380745 pmcid: 4522501
Richardson, A. S. C. et al. Extracorporeal cardiopulmonary resuscitation in adults. Interim Guideline Consensus Statement from the Extracorporeal Life Support Organization. ASAIO J. 67(3), 221–228. https://doi.org/10.1097/MAT.0000000000001344 (2021).
doi: 10.1097/MAT.0000000000001344 pubmed: 33627592
Belanger, F., Ung, A. & Falzon, A. Accidental poisoning-related deaths in an enlarged European Union. European Project ANAMORT Monographs. https://ec.europa.eu/health/ph_projects/2004/action1/docs/action1_2004_frep_22_a8_en.pdf (Accessed 6 March 2023) (2008).
Suicide. https://www.who.int/news-room/fact-sheets/detail/suicide (Accessed 6 March 2023).
Mowry, J. B., Spyker, D. A., Brooks, D. E., McMillan, N. & Schauben, J. L. 2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 32nd Annual Report. Clin. Toxicol. 53(10), 962–1147. https://doi.org/10.3109/15563650.2015.1102927 (2015).
doi: 10.3109/15563650.2015.1102927
Lott, C. et al. European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances. Resuscitation 161, 152–219. https://doi.org/10.1016/j.resuscitation.2021.02.011 (2021).
doi: 10.1016/j.resuscitation.2021.02.011 pubmed: 33773826
RDC of the Federal Statistical Office and Statistical Offices of the Federal States. Fallpauschalenbezogene Krankenhausstatistik (DRG-Statistik) 2007–2022. https://doi.org/10.21242/23141.2007.00.00.1.1.0 .
Elixhauser, A., Steiner, C., Harris, D. R. & Coffey, R. M. Comorbidity measures for use with administrative data. Med. Care 36(1), 8–27. https://doi.org/10.1097/00005650-199801000-00004 (1998).
doi: 10.1097/00005650-199801000-00004 pubmed: 9431328
van Walraven, C., Austin, P. C., Jennings, A., Quan, H. & Forster, A. J. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med. Care 47(6), 626–633. https://doi.org/10.1097/MLR.0b013e31819432e5 (2009).
doi: 10.1097/MLR.0b013e31819432e5 pubmed: 19433995
Köppel, C., Oberdisse, U. & Heinemeyer, G. Clinical course and outcome in class IC antiarrhythmic overdose. J. Toxicol. Clin. Toxicol. 28(4), 433–444. https://doi.org/10.3109/15563659009038586 (1990).
doi: 10.3109/15563659009038586 pubmed: 2176700
Paredes, V. L. et al. Out-of-hospital care of critical drug overdoses involving cardiac arrest. Acad. Emerg. Med. 11(1), 71–74. https://doi.org/10.1197/j.aem.2003.08.014 (2004).
doi: 10.1197/j.aem.2003.08.014 pubmed: 14709431
Weiner, L. et al. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: A retrospective study of the Extracorporeal Life Support Organizations’ ECMO case registry. Clin. Toxicol. 58(7), 705–710. https://doi.org/10.1080/15563650.2019.1676896 (2020).
doi: 10.1080/15563650.2019.1676896
Ramanathan, K., Tan, C. S., Rycus, P. & MacLaren, G. Extracorporeal membrane oxygenation for poisoning in adult patients: Outcomes and predictors of mortality. Intens. Care Med. 43(10), 1538–1539. https://doi.org/10.1007/s00134-017-4842-9 (2017).
doi: 10.1007/s00134-017-4842-9
Friedrichson, B., Mutlak, H., Zacharowski, K. & Piekarski, F. Insight into ECMO, mortality and ARDS: A nationwide analysis of 45,647 ECMO runs. Crit. Care 25(1), 38. https://doi.org/10.1186/s13054-021-03463-2 (2021).
doi: 10.1186/s13054-021-03463-2 pubmed: 33509228 pmcid: 7841040
Friedrichson, B. et al. Extracorporeal membrane oxygenation in coronavirus disease 2019: A nationwide cohort analysis of 4279 runs from Germany. Eur. J. Anaesthesiol. 39(5), 445–451. https://doi.org/10.1097/EJA.0000000000001670 (2022).
doi: 10.1097/EJA.0000000000001670 pubmed: 35180152
Jasny, T. et al. Results from 237 extracorporeal membrane oxygenation runs with drowned patients: A nationwide retrospective study. Crit. Care 27(1), 293. https://doi.org/10.1186/s13054-023-04580-w (2023).
doi: 10.1186/s13054-023-04580-w pubmed: 37474978 pmcid: 10360217
Masson, R. et al. A comparison of survival with and Sedation in poisoned patients that possibly ingested multiple substance classes or where ingested substance classes are not known initially can be especially tricky. Without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation 83(11), 1413–1417. https://doi.org/10.1016/j.resuscitation.2012.03.028 (2012).
doi: 10.1016/j.resuscitation.2012.03.028 pubmed: 22469751
Mégarbane, B. et al. Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest. Intens. Care Med. 33(5), 758–764. https://doi.org/10.1007/s00134-007-0568-4 (2007).
doi: 10.1007/s00134-007-0568-4
Daubin, C. et al. Extracorporeal life support in severe drug intoxication: A retrospective cohort study of seventeen cases. Crit. Care 13(4), R138. https://doi.org/10.1186/cc8017 (2009).
doi: 10.1186/cc8017 pubmed: 19706166 pmcid: 2750196
Babatasi, G. et al. Severe intoxication with cardiotoxic drugs: Value of emergency percutaneous cardiocirculatory assistance. Arch. Mal Coeur Vaiss. 94(12), 1386–1392 (2001).
pubmed: 11828924
Brunet, J. et al. Extracorporeal life support for refractory cardiac arrest or shock: A 10-year study. ASAIO J. 61(6), 676. https://doi.org/10.1097/MAT.0000000000000282 (2015).
doi: 10.1097/MAT.0000000000000282 pubmed: 26366684
Pozzi, M. et al. Veno-arterial extracorporeal membrane oxygenation for drug intoxications: A single center, 14-year experience. J. Card. Surg. 37(6), 1512–1519. https://doi.org/10.1111/jocs.16456 (2022).
doi: 10.1111/jocs.16456 pubmed: 35353389
Langer, T. et al. “Awake” extracorporeal membrane oxygenation (ECMO): Pathophysiology, technical considerations, and clinical pioneering. Crit. Care 20(1), 150. https://doi.org/10.1186/s13054-016-1329-y (2016).
doi: 10.1186/s13054-016-1329-y pubmed: 27357690 pmcid: 4928342
Haji, J. Y., Mehra, S. & Doraiswamy, P. Awake ECMO and mobilizing patients on ECMO. Indian J. Thorac. Cardiovasc. Surg. 37(Suppl 2), 309–318. https://doi.org/10.1007/s12055-020-01075-z (2021).
doi: 10.1007/s12055-020-01075-z pubmed: 33487891 pmcid: 7811888
Yu, X., Gu, S., Li, M. & Zhan, Q. Awake extracorporeal membrane oxygenation for acute respiratory distress syndrome: Which clinical issues should be taken into consideration. Front. Med. 8, 682526. https://doi.org/10.3389/fmed.2021.682526 (2021).
doi: 10.3389/fmed.2021.682526
Buckley, N. A., Whyte, I. M., Dawson, A. H., McManus, P. R. & Ferguson, N. W. Self-poisoning in Newcastle, 1987–1992. Med. J. Aust. 162(4), 190–193. https://doi.org/10.5694/j.1326-5377.1995.tb126020.x (1995).
doi: 10.5694/j.1326-5377.1995.tb126020.x pubmed: 7877540
Michel, K., Waeber, V., Valach, L., Arestegui, G. & Spuhler, T. A comparison of the drugs taken in fatal and nonfatal self-poisoning. Acta Psychiatr. Scand. 90(3), 184–189. https://doi.org/10.1111/j.1600-0447.1994.tb01575.x (1994).
doi: 10.1111/j.1600-0447.1994.tb01575.x pubmed: 7810341
Shields, L. B. E., Hunsaker, D. M., Hunsaker, J. C. & Ward, M. K. Toxicologic findings in suicide: A 10-year retrospective review of Kentucky medical examiner cases. Am. J. Forensic Med. Pathol. 27(2), 106–112. https://doi.org/10.1097/01.paf.0000220913.19508.99 (2006).
doi: 10.1097/01.paf.0000220913.19508.99 pubmed: 16738426

Auteurs

Benjamin Friedrichson (B)

Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany. ben@dsgfrankfurt.de.

Thomas Jasny (T)

Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.

Oliver Old (O)

Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.

Florian Piekarski (F)

Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
Department of Anesthesiology and Intensive Care Medicine, Rheinische Friedrich-Wilhelms-University, University Hospital Bonn, Bonn, Germany.

Angelo Ippolito (A)

Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.

Florian J Raimann (FJ)

Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.

Kai Zacharowski (K)

Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.

Jan Andreas Kloka (JA)

Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH